JETEMA, Co., Ltd.
Research JETEMA, Co., Ltd. (216080.KQ) on Bullrun: market cap KRW 223.35B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker216080.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyKRW
- Market capKRW 223.35B
- Financial periodQ2 2026
- RevenueKRW 20.08B
- Net incomeKRW 1.60B
- Free cash flowKRW 2.24B
- Gross margin50.7%
Valuation Snapshot
latest market cap is KRW 223.35B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 223.35B | n/a | n/a | n/a |
Dividend history
About JETEMA, Co., Ltd.
JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers clostridium botulinum toxins, fillers, lifting threads for medical treatment, elastin and collagen stimulate solution under Ecolla, and healthy skin care under vitten brand names. The company also provides skin care hyaluronic acid masks. JETEMA, Co., Ltd. was founded in 2009 and is headquartered in Wonju-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is JETEMA, Co., Ltd.'s market cap?
JETEMA, Co., Ltd.'s market capitalization is KRW 223.35B.
What does JETEMA, Co., Ltd. do?
JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers clostridium botulinum toxins, fillers, lifting threads for medical treatment, elastin and collagen stimulate solution under Ecolla, and healthy skin care under vitten brand names. The company also provides skin care hyaluronic acid masks. JETEMA, Co., Ltd. was founded in 2009 and is headquartered in Wonju-si, South Korea.